相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Cyclic GMP and PKG Signaling in Heart Failure
Genri Numata et al.
FRONTIERS IN PHARMACOLOGY (2022)
Is There Value in Repeating Inhaled Nitric Oxide Vasoreactivity Tests in Patients with Pulmonary Arterial Hypertension?
Rubabin Tooba et al.
LUNG (2020)
Prognostic Value of Follow-Up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension
Jason Weatherald et al.
CIRCULATION (2018)
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)
Nazzareno Galie et al.
EUROPEAN HEART JOURNAL (2016)
BMPR2 mutation status influences bronchial vascular changes in pulmonary arterial hypertension
Maria-Rosa Ghigna et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Five-Year Outcomes of Patients Enrolled in the REVEAL Registry
Harrison W. Farber et al.
CHEST (2015)
Residual pulmonary vasodilative reserve predicts outcome in idiopathic pulmonary hypertension
Hanno H. Leuchte et al.
HEART (2015)
Prognostic value of acute vasodilator response in pulmonary arterial hypertension: Beyond the classic responders
Stephen J. Halliday et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2015)
Pulmonary Arterial Hypertension The Clinical Syndrome
Yen-Chun Lai et al.
CIRCULATION RESEARCH (2014)
The Role of Nitric Oxide on Endothelial Function
Dimitris Tousoulis et al.
CURRENT VASCULAR PHARMACOLOGY (2012)
Nitric oxide synthases: regulation and function
Ulrich Foerstermann et al.
EUROPEAN HEART JOURNAL (2012)
The prognostic impact of follow-up assessments in patients with idiopathic pulmonary arterial hypertension
N. Nickel et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
Mechanisms of disease: pulmonary arterial hypertension
Ralph T. Schermuly et al.
NATURE REVIEWS CARDIOLOGY (2011)
Vasoreactivity to Inhaled Nitric Oxide with Oxygen Predicts Long-Term Survival in Pulmonary Arterial Hypertension
Rajeev Malhotra et al.
Pulmonary Circulation (2011)
Pulmonary vasodilator testing and use of calcium channel blockers in pulmonary arterial hypertension
Adriano R. Tonelli et al.
RESPIRATORY MEDICINE (2010)
Contribution of oxidative stress to pulmonary arterial hypertension
Vincent G. DeMarco et al.
WORLD JOURNAL OF CARDIOLOGY (2010)
Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure
Kurt R. Stenmark et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2009)
Nitric oxide and beyond: new insights and therapies for pulmonary hypertension
R. H. Steinhorn
JOURNAL OF PERINATOLOGY (2008)
Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension
O Sitbon et al.
CIRCULATION (2005)
Oxidative stress in severe pulmonary hypertension
R Bowers et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Hemodynamic response to sildenafil, nitric oxide, and iloprost in primary pulmonary hypertension
HH Leuchte et al.
CHEST (2004)
Cellular and molecular pathobiology of pulmonary arterial hypertension
M Humbert et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)